Clinical Trials Do Not Accurately Represent Patient Diversity in Hematologic Cancers
Recommended
Clinical Trials Do Not Accurately Represent Patient Diversity in Hematologic Cancers
Clinical trials leading to the approval of drugs for patients with leukemia or multiple myeloma (MM) may not accurately represent the patient groups intended for treatment, according to research published in the Journal of Clinical Oncology.
<!-- BEGIN ADVERTSERVE CODE -->
<div id="mobile_block_ad_1"><script type="text/javascript">
var _avp = _avp || [];
_avp.push({ tagid: 'mobile_block_ad_1', alias: '/', type: 'banner', zid: 1669, pid: 0, onscroll: 0, inview: true, secure: true });
</script></div>
<!-- END ADVERTSERVE CODE -->